Editor's Note In this study, researchers from Henry Ford Health System in Michigan found that hydroxychloroquine alone decreased the mortality hazard ratio of COVID-19 by 66%, and hydroxychloroquine with azithromycin decreased the ratio by 71%, compared to neither treatment. The vast majority of the 2,541 COVID-19 patients included in the…
Editor's Note: The American College of Physicians (ACP) on June 18 issued new practice points on the effectiveness of N95 respirators, surgical masks, and cloth masks for the prevention of COVID-19 in addition to standard precautions in healthcare and community settings. The ACP Practice Points, which were funded by the…
Editor's Note The Lancet and New England Journal of Medicine (NEJM) have both retracted COVID-19 treatment studies because of concerns about the validity of the data and how the research was conducted by Chicago-based Surgisphere Corp, the June 4 Medscape Medical News reports. Authors of the Lancet study, which was…
Editor's Note The National Institutes of Health (NIH) on May 14 announced that it is enrolling adults with mild to moderate COVID-19 in a study of treatment with hydroxychloroquine and azithromycin. The Phase 2b trial is enrolling around 2,000 adults across the US. Participants must have confirmed infection with SARS-CoV-2…
Editor's Note Treating hospitalized COVID-19 patients with anticoagulants may improve their chances of survival, this study from Mount Sinai finds. Of 2,773 COVID-19 patients analyzed, 786 received a full-treatment dose of anticoagulants, which was a higher dose than that typically given for clot prevention; it is one usually given to…
Editor's Note Researchers at Northwestern University in Chicago are using artificial intelligence (AI) to expedite the search for COVID-19 treatments and vaccines by shortening the expert review period. The AI tool prioritizes research that has the most potential to produce real solutions and ignores research that is unlikely to yield…
Editor's Note Cornell University researchers studying the structure of the SARS-CoV-2 virus have found a unique feature that could explain why it is so transmissible between humans. The researchers identified a structural loop in the SARS-CoV-2 spike protein (ie, the area of the virus that facilitates entry into a cell)…
Editor's Note A new novel coronavirus (SARS-CoV-2), which causes the disease COVID-19, is the third highly pathogenic human coronavirus that has emerged in the last two decades. The other two are the Severe Acute Respiratory Syndrome (SARS) and Middle East Respirtory Syndrome (MERS) coronaviruses. This analysis of 22 studies finds…
Over the last 5 years, the perioperative surgical home (PSH) model has attracted increasing interest from OR directors, anesthesiologists, and surgeons. This team-based, patient-centered approach coordinates all phases of surgical care, from preoperative assessment through intraoperative care and postdischarge recovery. According to the American Society of Anesthesiologists, PSH initiatives have…
Virginia Commonwealth University Health System (VCU Health) in Richmond is a Magnet facility, and as such we continually examine innovative ideas to improve the quality, safety, and care of our patients. Evidence has linked Enhanced Recovery After Surgery (ERAS) with better outcomes, and ERAS has become a focal point at…